NM_007194.4:c.1284T>G

Variant names:

• chr22-28695218-A-C
• rs781514295
• NM_007194.4:c.1284T>G

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM2 BP4_Strong BP6_Very_Strong BP7

The NM_007194.4(CHEK2):​c.1284T>G​(p.Ser428Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S428S) has been classified as Likely benign.

• Frequency:
  • Genomes: not found (cov: 32)
  • Exomes 𝑓: 6.9e-7 (0 hom.)
  • Failed GnomAD Quality Control
• Consequence: CHEK2 NM_007194.4 synonymous
• Clinical Significance: Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2
• Conservation: PhyloP100: 1.65
• Publications: 0 publications found

Genes affected

CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

CHEK2 Gene-Disease associations (from GenCC):

• CHEK2-related cancer predisposition

  Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
• hereditary breast carcinoma

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
• Li-Fraumeni syndrome 2

  Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
• acute myeloid leukemia

  Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
• hereditary nonpolyposis colon cancer

  Inheritance: AD Classification: LIMITED Submitted by: ClinGen
• familial ovarian cancer

  Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

ACMG classification

Our verdict: Benign. The variant received -11 ACMG points.

• PM2: Very rare variant in population databases, with high coverage
• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.52).
• BP6: Variant 22-28695218-A-C is Benign according to our data. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-28695218-A-C is described in CliVar as Benign/Likely_benign. Clinvar id is 818798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BP7: Synonymous conserved (PhyloP=1.65 with no splicing effect.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CHEK2	NM_007194.4	c.1284T>G	p.Ser428Ser	synonymous_variant	Exon 12 of 15	ENST00000404276.6	NP_009125.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CHEK2	ENST00000404276.6	c.1284T>G	p.Ser428Ser	synonymous_variant	Exon 12 of 15	1	NM_007194.4	ENSP00000385747.1

Frequencies

GnomAD3 genomes Cov.: 32

GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 6.85e-7 AC: 1 AN: 1459134 Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0 AN XY: 726078

African (AFR) AF: 0.00 AC: 0 AN: 33412

American (AMR) AF: 0.00 AC: 0 AN: 44698

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 26100

East Asian (EAS) AF: 0.0000252 AC: 1 AN: 39666

South Asian (SAS) AF: 0.00 AC: 0 AN: 86180

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 53396

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 5760

European-Non Finnish (NFE) AF: 0.00 AC: 0 AN: 1109652

Other (OTH) AF: 0.00 AC: 0 AN: 60270

GnomAD4 genome Cov.: 32

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

Hereditary cancer-predisposing syndrome Benign:1

Jan 14, 2019

Ambry Genetics

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Familial cancer of breast Benign:1

Oct 07, 2024

Myriad Genetics, Inc.

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.52
CADD	Benign	15
DANN	Benign	0.73
PhyloP100		1.7
Mutation Taster		=100/0	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs781514295; hg19: chr22-29091206;